Microbot Medical Inc. (MBOT) stock
MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.68−0.06 (-8.52%)
Close on Nov 20, 2026Market cap $45.67MP/E –Yield –
Microbot Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Microbot Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$17.93M. For fiscal 2025 it was -$13.11M. The highest annual figure on record is -$767.00K in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.11M | – |
| FY2024 | Dec 31, 2024 | -$8.85M | – |
| FY2023 | Dec 31, 2023 | -$8.57M | – |
| FY2022 | Dec 31, 2022 | -$11.63M | – |
| FY2021 | Dec 31, 2021 | -$9.42M | – |
| FY2020 | Dec 31, 2020 | -$7.34M | – |
| FY2019 | Dec 31, 2019 | -$6.67M | – |
| FY2018 | Dec 31, 2018 | -$5.53M | – |
| FY2017 | Dec 31, 2017 | -$4.91M | – |
| FY2016 | Dec 31, 2016 | -$811.00K | – |
| FY2015 | Dec 31, 2015 | -$767.00K | – |
| FY2014 | Dec 31, 2014 | -$28.26M | – |
| FY2013 | Dec 31, 2013 | -$28.00M | – |
| FY2012 | Dec 31, 2012 | -$19.94M | – |
| FY2011 | Dec 31, 2011 | -$22.36M | – |
| FY2010 | Dec 31, 2010 | -$25.44M | – |
| FY2009 | Dec 31, 2009 | -$25.38M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.58M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.76M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.43M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.82M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.68M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.02M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.93M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.19M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.30M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.88M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.70M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.41M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.35M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.44M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.33M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.34M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.35M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.44M | – |
| Q1 FY2017 | Mar 31, 2017 | -$789.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$28.57K | – |
| Q3 FY2016 | Sep 30, 2016 | -$421.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$62.50K | – |
See a number that looks wrong?